INTRODUCTION {#sec1-1}
============

Regeneration is defined as the reproduction or reconstitution of a lost or injured a part of the body in such a way that the architecture and function of the lost or injured tissues are completely restored.\[[@ref1]\] The complex series of events associated with periodontal regeneration involves recruitment of locally derived progenitor cells to the site. The progenitor cells can subsequently differentiate into periodontal ligament-forming cells, cementoblasts, or bone-forming osteoblasts.\[[@ref2]\] Therefore, the key to periodontal regeneration is to stimulate the progenitor cells to re-occupy the defects.\[[@ref3]\] Growth factors are vital modulators during this process which can induce the migration, attachment, proliferation, and differentiation of periodontal progenitor cells.\[[@ref4]\]

This led periodontal researchers and clinicians to focus on the use of polypeptide growth factors for periodontal regeneration.\[[@ref5][@ref6][@ref7]\] It was shown that osteoblasts proliferate in response to platelet-derived growth factor (PDGF) alone or with the addition of a progression factor to induce mitosis.\[[@ref8][@ref9]\] Transforming growth factor-β (TGF-β), a multifunctional growth factor that is chemotactic for bone cells, increases the differentiated function of osteoblasts, osteoblast precursors, and extracellular matrix formation, such as type I collagen,\[[@ref10]\] and stimulates the proliferation of gingival fibroblastic cells, the formation of blood vessels, the re-modeling of extracellular matrix, and the formation of granulation tissue during the healing of periodontal tissue.\[[@ref11]\] Platelet-rich plasma (PRP) is an autologous source of PDGF and TGF-β that is obtained by isolating and concentrating human platelets to 338% by gradient density centrifugation.\[[@ref12]\]

Various researchers have investigated if a combination of regenerative therapies would promote maximum resolution of the defects. Since then, bone replacement grafting has been combined with a synthetic cell-binding peptide (P-15), guided tissue regeneration (GTR), enamel matrix derivative, and PRP.\[[@ref13][@ref14][@ref15][@ref16][@ref17]\] However, other studies\[[@ref18][@ref19][@ref20][@ref21]\] suggested that the use of PRP failed to improve the results obtained with GTR and bone substitutes. de Obarrio *et al*.\[[@ref22]\] presented case reports in which platelet gel was used successfully in combination with demineralized freeze-dried bone graft (DFDBA) for the treatment of periodontal osseous defects. The combination of PRP and DFDBA was compared to the combination of DFDBA and saline in a study by Piemontese *et al*.\[[@ref23]\] and PRP alone in a study by Ilgenli *et al*.\[[@ref24]\]

Therefore, this study was conducted with the aim to compare the clinical and radiographic effectiveness of PRP when used alone and when added to DFDBA in the treatment of periodontal endosseous defects. The study also evaluates the effects of the two treatment modalities independently when compared to control group, that is, receiving open flap debridement (OFD) alone.

MATERIALS AND METHODS {#sec1-2}
=====================

Patient and defect selection {#sec2-1}
----------------------------

Ten patients (7 males and 3 females) were selected from the outpatient department of the Institute of Dental Sciences, Bareilly. Signed consent was obtained from patients, and the study was approved by the Ethics Committee of MJP Rohilkhand University, Bareilly. Thirty infrabony defects were included in the study.

The inclusion criteria were adult patients in good general health and diagnosed with chronic advanced periodontitis based on the 1999 consensus classification of periodontal diseases,\[[@ref25]\] presence of three deep intrabony defects (three-walled) with a probing depth (PD) \>5 mm located in the interproximal area in maxillary or mandibular posterior teeth in three different quadrants. Radiographic evidence of the defects should exist. Base line radiographs should reveal a defect depth (distance from cemento-enamel junction \[CEJ\] to the base of the defect) of minimum 4 mm.

Exclusion criteria included smoking, antibiotic, or anti-inflammatory treatment or the known use of any medication with the potential to affect periodontal tissues within the preceding 6 months, and pregnancy.

The defects were assigned randomly to three groups. The control group (C) consisted of sites treated with OFD alone. Whereas, test group A consisted of sites treated with PRP alone and test group B received PRP in combination with DFDBA. The patient and defect characteristics of the three groups at baseline yielded no significant differences among any of the patient-associated variables or baseline levels of defect depth.

Presurgical therapy {#sec2-2}
-------------------

Prior to the surgery, each patient was given careful instructions on proper oral hygiene measures. Full mouth supra- and sub-gingival scaling and root planning procedures were performed under local anesthesia. In addition, occlusal stents were fabricated at this stage with cold-cured acrylic resin on a cast model obtained from an alginate impression. To assess the tissue changes reproducibly, grooves were placed on the occlusal stents to compare the pre- and post-surgical measurements. Six to Eight weeks following phase I therapy, periodontal evaluation was performed to confirm the suitability of the sites for this study.

Clinical parameters recorded at baseline and 12 months after surgery were plaque index (PI),\[[@ref26]\] gingival index (GI),\[[@ref26]\] PD, and clinical attachment level (CAL). Measurements were performed with a manual periodontal probe^δ^ and recorded. Intra-examiner calibration was achieved by examination of 10 patients twice, 24 h apart before beginning the study. Calibration was accepted if measurements at baseline and 24 h were similar to ± 1 mm at the 90% level. The method was previously described by Pradeep *et al*.\[[@ref27]\]

In addition to, clinical measurements and radiographs were taken to measure the radiographic defect depth reduction and defect resolution. The standardized radiographs were taken using the conventional long-cone technique. Defect fill was assessed by measuring distance between CEJ and base of the defect (BD). The distance between alveolar crest (AC) and BD depicted defect resolution. Change in AC level was also seen as a measurement of distance between CEJ and AC.

Preparation of platelet-rich plasma {#sec2-3}
-----------------------------------

Approximately, 20 ml blood was drawn from each patient by venipuncture of the antecubital vein, on the day of surgery. Blood was collected in sterile plastic test tubes that contained anticoagulant. The blood containing test tubes were shaken gently to enhance complete mixing of the blood with anticoagulant. They were kept at room temperature for a minimum of 45 min to minimize the complement activity. Later, blood containing test tubes were centrifuged using centrifugal machine at 3000, revolutions/min for 10 min, which resulted in the separation of three basic fractions because of differential densities: The bottom red blood cells (RBCs), middle PRP, and the top layer of platelet poor plasma (PPP). A total of 2--3 ml of the top layer, corresponding to the PPP, was aspirated with a pipette and collected in a separate sterile plastic tube. The PRP was collected along with the top 1--2 mm of RBC fraction because it is also rich in newly synthesized platelets.\[[@ref28]\]

PRP was activated to a gel form using 10% CaCl~2~ and autologous thrombin, the latter being prepared from PPP as described by Su *et al*.\[[@ref29]\]

Surgical procedure {#sec2-4}
------------------

Following administration of local anesthesia, buccal, and lingual sulcular incisions were made, and mucoperiosteal flaps were elevated. Care was taken to preserve as much interproximal soft tissue as possible.

Meticulous defect debridement and root planning were carried out with the use of ultrasonic instruments and curettes. No osseous re-contouring was done. DFDBA graft particles were mixed with coagulated autologous PRP preparation (1:1) in a sterile dappen dish.\[[@ref28]\] This mixture was properly condensed in the test site to the level of the surrounding bony walls in test group B. Autologous PRP, in the gel form was packed into the defect in the test group A.

Postoperative care {#sec2-5}
------------------

All patients were prescribed 500 mg amoxicillin three times daily for 1 week, and instructed to rinse with 0.12% chlorhexidine for at least 3 weeks, twice a day. Dressing and sutures were removed 1 week postoperatively. Patients were examined weekly for 1 month after surgery and then at 3, 6, 9, and 12 months. Postoperative care included reinforcement of oral hygiene and mechanical plaque control whenever necessary. Subgingival instrumentation was avoided before 12 months to prevent the disruption of developing attachment apparatus.

Posttreatment assessments {#sec2-6}
-------------------------

All the clinical parameters, PI, GI, PD, and CAL, were recorded 12 months postoperatively using previously used acrylic stents. Periapical radiographs were taken after 12 months using paralleling technique to maintain standardization. These radiographs were scanned with HP Epson scanner. Computer-assisted image analysis of the radiographs was done with the help of image analysis software (AutoCad Ver2004; Autodesk, California, United States).

Statistical analysis {#sec2-7}
--------------------

Mean values and standard deviations were calculated for all clinical and radiographic parameters at baseline and 12 months. Taking into account the paired nature of the changes from baseline to 12 months in each group, the Wilcoxon signed rank matched pair test was performed for the pair-wise statistical analysis of these data. The Mann--Whitney U-test was applied to compare clinical and radiographic outcomes between three groups (two groups at a time) at baseline, 12 months postsurgery and differences due to the time interval. All the calculations were performed using Statistical Package of Social Sciences (IBM SPSS Statistics; New York, United States), version 10.

RESULTS {#sec1-3}
=======

A total of 10 patients (30 sites) participated in the study. Two patients did not turn up for the third surgery making a total of 28 sites. Of these 10 sites were treated with PRP alone, 9 sites with PRP + DFDBA and 9 sites with OFD alone. The treatment groups were initially comparable. All treated cases showed uneventful wound healing. A statistically significant reduction in the PI and GI was observed in all three groups at 12 months postoperatively (*P* \< 0.01) \[[Table 1](#T1){ref-type="table"}\].

###### 

Mean and SD of GI and PI at baseline, at 12 months and difference between pre- and post-measurements

![](JISP-20-42-g001)

Mean values for pocket PD, CAL, and gingival recession at baseline and 12 months with mean changes are reported in [Table 2](#T2){ref-type="table"}. Both, PRP + DFDBA and PRP sites presented with a significantly greater PD reduction CAL gain than control sites at 12 months postoperatively. Defect depth reduction was found to be significantly greater (*P* \< 0.01) in the PRP group (3.42 ± 0.62) and PRP + DFDBA group (3.89 ± 0.68) than OFD alone (0.15 ± 0.28) \[[Table 2](#T2){ref-type="table"}\]. PRP + DFDBA treated group showed greater defect depth reduction than PRP alone (*P* \< 0.01) \[[Table 3](#T3){ref-type="table"}\]. In terms of percentage, defect depth reduction in PRP group (40.19%) was significantly \<PRP + DFDBA group (47.18%), but significantly greater than control group (1.75%) \[[Table 3](#T3){ref-type="table"}\]. Similar results were obtained for defect resolution. PRP + DFDBA showed significantly greater resolution (2.37 ± 0.65) than PRP alone (1.90 ± 0.51) at *P* \< 0.05. The results of PRP were significantly greater than control group (0.13 ± 0.52) at *P* \< 0.01 \[[Table 3](#T3){ref-type="table"}\].

###### 

Mean and SD of PD, CAL and amount of recession at baseline, at 12 months and difference between pre- and post-measurements
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###### 

Mean and SD of amount of defect depth reduction, bone resolution and crestal bone loss at baseline, at 12 months and difference between pre- and post-measurements

![](JISP-20-42-g003)

DISCUSSION {#sec1-4}
==========

The present study was designed to assess the outcome of the two regenerative techniques, that is, PRP alone and PRP in conjunction with DFDBA in treating periodontal intrabony defects and also compares their effectiveness using clinical and radiographic parameters.

Only three-wall intrabony periodontal defects (IBDs) are included in the present study because the number of bony walls remaining has been found to be positively correlated with regeneration potential when grafting procedures were used.\[[@ref30][@ref31][@ref32]\] Three-wall-containing defects have been shown to provide the best spatial relationship for defect bridging by vascular and cellular elements from the periodontal ligament and adjacent osseous wall.\[[@ref33]\] Statistically, clinical and radiographic parameters of the subjects were similar in all the three groups at baseline. All participants maintained an acceptable oral hygiene.

In this study, a significant reduction in PD and CAL gain is found in all three groups when compared with baseline and 12 months. However, there was more PD reduction (4.88 ± 1.18 mm) in the PRP + DFDBA-treated and PRP-treated groups (4.86 ± 1.18 mm) compared with the participants treated with conventional periodontal flap surgery alone. Similarly, CAL gain was more in PRP + DFDBA-treated (4.26 ± 1.85 mm) and PRP-treated groups (4.10 ± 1.47 mm) than OFD alone.

Richardson *et al*.\[[@ref34]\] and Bender *et al*.\[[@ref35]\] evaluated the treatment of human vertical intrabony defects with DFDBA at 6 months postsurgery; they found a PD reduction of 2.0 and 2.8 mm and a CAL gain of 2.6 and 2.4 mm, respectively.

The greater CAL gain and PD reduction observed in the DFDBA + PRP group in the present study may be explained by the additional biologic effects of PRP. The mechanism of action of PRP is attributed to several of its cellular effects. Marx *et al*.\[[@ref12]\] demonstrated that the platelet stored growth factors and its specific cell receptors. PRP fractions promote important cell responses involved in tissue repair including fibroblast migration, cell adhesion, and myeloblastic differentiation of gingival fibroblasts\[[@ref36]\] resulting in accelerated soft and hard tissue healing.\[[@ref37]\] PRP has a favorable effect on human osteoclast-like cells, and acts both to enhance bone regeneration and as an activator in wound healing.\[[@ref38]\]

Only, a few studies have been conducted to evaluate the influence of PRP alone on bone healing. The treatment of bony defects with PRP alone, in the femurs or calvaria of rabbits or the mandibles of dogs, showed no improvement of bone formation.\[[@ref39][@ref40][@ref41]\] Conversely, favorable results were reported by Anitua,\[[@ref42]\] Sammartino *et al*.,\[[@ref43]\] and Simon *et al*.\[[@ref44]\] in the bone healing of extraction sockets treated with PRP only. In intrabony defects, only few studies have been conducted using PRP alone\[[@ref24][@ref28][@ref32][@ref45]\] and the results are inconclusive.

In our study, mean intrabony defect depth reduction in the PRP group was 3.42 ± 0.62 mm. although it was significantly \<PRP + DFDBA group (3.89 ± 0.68 mm), but it was significantly higher than OFD alone (0.15 ± 0.28 mm). Percentage reduction in defect depth obtained in our study for PRP group (40.18 ± 1.29) was although lesser than previous studies by Pradeep *et al*.,\[[@ref27][@ref32]\] but it was comparable with that obtained with PRP + DFDBA (47.19 ± 0.97). Although numerous studies have reported the treatment of periodontal intrabony defects using PRP, this study compares the effectiveness of PRP with OFD on one hand and with allograft combined with PRP, which has established high efficacy, on the other hand.

The discrepancy between the clinical (PD and CAL) outcomes and radiographic IBD in the control group may be attributable to the fact that OFD may have resulted in the presence of a long junctional epithelium between the newly regenerated tissues and the root surface and not true bone regeneration. This was similar to results obtained by Pradeep *et al*.\[[@ref32]\] in their study, where CAL gain in OFD group was 2.83 ± 0.91 and defect depth reduction was only 0.13 ± 1.46.

The aim of periodontal therapy is to achieve a gain in CAL and return the periodontal tissues to a healthy state. The results of our study showed that PRP + DFDBA treated group showed most favorable clinical and radiographic outcomes. This was substantiated by various studies in the literature. Hanna *et al*.\[[@ref46]\] reported a CAL gain of 3.15 mm for the PRP/bovine-derived xenograft, group. Okuda *et al*.\[[@ref47]\] demonstrated a mean CAL gain of 3.4 ± 1.7 mm and a mean defect fill of 3.5 ± 1.5 mm with PRP/porous HA and concluded that adding PRP to HA led to a significantly more favorable clinical improvement in the treatment of IBDs. Lekovic *et al*.\[[@ref17]\] demonstrated a defect fill of 4.82 ± 1.34 mm at 21 sites treated with PRP/bovine porous bone mineral. The varying results from different studies may derive from the use of different graft materials.

Although PRP preparation is autologous and economical, addition of an extra step to the surgical procedure and increase in time should also be considered.

CONCLUSION {#sec1-5}
==========

Majority of the studies in the past have been conducted using PRP as an adjunct to various bone substitutes. This has masked the evaluation of actual regenerative potential of PRP. Hence, this study is one of the few studies that compare the use of PRP alone with control that is, OFD. The study demonstrates that use of autologous PRP was effective in the treatment of intrabony defects. However, amount of defect depth reduction was lesser than that obtained with PRP + DFDBA, but it was significantly higher than OFD alone. Thus, considering its autologous nature and decrease in the cost, PRP offers an excellent option to the clinician for regenerative approach. Further, long-term clinical trials are required to substantiate this finding.

Financial support and sponsorship {#sec2-8}
---------------------------------

Nil.

Conflicts of interest {#sec2-9}
---------------------

There are no conflicts of interest.
